コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 known as regulators of G protein signaling (RGS proteins).
2 Pases in the intracellular trafficking of an RGS protein.
3 one Galpha, one Gbeta, three Ggamma, and one RGS protein.
4 t reversible small-molecule inhibitors of an RGS protein.
5 ied the first small-molecule inhibitor of an RGS protein.
6 urface expression and through recruitment of RGS proteins.
7 the Galpha subunit, a reaction catalyzed by RGS proteins.
8 Rs (MOR and D2R) on the G protein bias of R7 RGS proteins.
9 g G protein and GPCR selectivity of striatal RGS proteins.
10 ervous system, is mediated exclusively by R7 RGS proteins.
11 maintaining proteolytic stability of the R7 RGS proteins.
12 ctivity, to mimic in cis the GAP function of RGS proteins.
13 ise from the consensus GoLoco motif found in RGS proteins.
14 terization of cancer-associated mutations in RGS proteins.
15 face between Gbeta5 and the N terminus of R7 RGS proteins.
16 lated to differential protein dynamics among RGS proteins.
17 d pathway under strong inhibitory control by RGS proteins.
18 the extent of inhibition by the R4 family of RGS proteins.
19 subfamilies consisting of over 20 different RGS proteins.
20 f Galpha12, a behavior consistent with other RGS proteins.
21 cs and inhibitor potency for three different RGS proteins.
22 olecule inhibitors targeting a subset of the RGS proteins.
23 rotein cycle is regulated by the activity of RGS proteins.
24 s, and the REGULATOR OF G-PROTEIN SIGNALING (RGS) protein.
25 amily of "regulator of G protein signaling" (RGS) proteins.
26 eract with regulator of G protein signaling (RGS) proteins.
27 ivity of "regulator of G-protein signaling" (RGS) proteins.
28 rolled by regulator of G protein signalling (RGS) proteins.
29 led by the regulator of G protein signaling (RGS) proteins.
30 led by the regulator of G-protein signaling (RGS) proteins.
35 including nucleotide binding, intrinsic and RGS protein-accelerated GTP hydrolysis, and interactions
38 enuated by regulator of G protein signaling (RGS) proteins acting as GTPase-activating proteins for G
41 s there are concomitant, independent LSEs of RGS proteins along with an extraordinary diversification
43 rotein is readily inactivated by its cognate RGS protein and forms a stable, GDP-bound, heterotrimeri
44 protein-coupled receptors, Galpha subunits, RGS proteins and downstream effectors in mammalian syste
48 endrites by varying the concentration of key RGS proteins and measuring the impact on transmission of
49 provide a brief overview of the discovery of RGS proteins and of the gradual and continuing discovery
51 he catalytic activity of all canonical human RGS proteins and their selectivity for a complete set of
52 at the spatiotemporal-specific expression of RGS proteins and their target components, as well as the
53 th Loco, a regulator of G-protein signaling (RGS) protein and a known effector of glia specification.
54 lso binds regulators of G protein signaling (RGS) proteins and the third intracellular loop (3iL) of
55 o still bind the N-terminal DEP domain of R7 RGS proteins, and mutant Gbeta5-R7 RGS complexes initial
56 nteract with all members of the R7 family of RGS proteins, and palmitoylation of R7BP can target R7 R
58 protein inactivation, which is modulated by RGS proteins, and the rate of G protein activation, whic
59 including Regulator of G protein Signaling (RGS) proteins, and has been implicated in membrane targe
60 ypothesize Regulator of G-Protein Signaling (RGS) proteins, and specifically RGS5, are endogenous rep
63 regulator of Hh-mediated signaling and that RGS proteins are potential targets for novel therapeutic
83 Regulators of G protein signaling (RGSs, or RGS proteins) are responsible for the subsecond turn off
85 indings reveal a hitherto overlooked role of RGS proteins as noise suppressors and demonstrate an abi
86 nd also reveal a potential novel function of RGS proteins as positive regulators of opioid spinal ant
87 entify RGS6, a member of the R7 subfamily of RGS proteins, as a key regulator of GABA(B)R signaling i
88 f these small-molecule inhibitors against 12 RGS proteins, as well as against the cysteine-null mutan
92 cytes with a Galphai2 mutation that disables RGS protein binding accumulated in the perivascular chan
97 , we reveal these differences in dynamics of RGS proteins by partitioning the protein structural spac
98 uss a rationale for therapeutic targeting of RGS proteins by regulation of expression or allosteric m
105 we highlight the diverse mechanisms by which RGS protein complexes control plasticity in response to
106 annel assembly with allosterically regulated RGS protein complexes, which provide a target for modula
108 family of regulators of G protein signaling (RGS) proteins, comprising RGS6, RGS7, RGS9, and RGS11, r
109 For example, members of the R7 family of RGS proteins contain a DEP, GGL, and novel DHEX domain a
111 which is responsible for GAP activity, most RGS proteins contain other distinct structural motifs.
113 y a role in pathophysiological processes and RGS proteins could represent novel cardiovascular therap
120 at loss of RSBP-1 phenocopies loss of the R7 RGS protein EAT-16, but does not disrupt function of the
124 CCG-4986, lack of inhibition indicates that RGS proteins exhibit fundamental differences in their re
126 se and heart rate regulation, and changes in RGS protein expression and/or function are believed to p
129 etics, the regulator of G-protein signaling (RGS) protein family modulates the timing of GIRK activit
130 of the R7 regulators of G protein signaling (RGS) protein family of neuronal RGS, is a critical regul
131 ber of the Regulator of G protein Signaling (RGS) protein family, as a nuclear factor that suppresses
133 ongly suggests a causal relationship between RGS protein flexibility and covalent inhibitor potency.
134 r Galpha(i)G203A), as well as GRK2NT-GFP (an RGS protein for G(q/11)) but neither p115RhoGEFRGS-GFP (
135 ich has the largest complement of Galpha and RGS proteins for any eukaryote, provides new insights in
136 of the regulators of G-protein signaling (R7 RGS) proteins form multi-subunit complexes that play cru
137 Most studies searching for modulators of RGS protein function have been focused on inhibiting the
138 ors have been identified; however, enhancing RGS protein function is often more clinically desirable
140 Recent findings have established that R7 RGS proteins function as macromolecular complexes with t
141 t is unclear which of the more than 20 known RGS proteins function to negatively regulate and thereby
143 ai2 (G184S/G184S) mutation that disables all RGS protein/Galphai2 interactions exhibit an unexpectedl
149 , while G-proteins are widespread in plants, RGS proteins have been reported to be missing from the e
152 targeting conserved cysteine residues among RGS proteins have emerged as potential candidates to inh
154 ctions between activated Galpha subunits and RGS proteins have yielded a substantial number of inhibi
155 Endogenous regulator of G-protein signaling (RGS) proteins have been implicated as key inhibitors of
156 y, several regulator of G protein signaling (RGS) proteins have emerged as critical modulators of PD
157 mid-1990s, regulator of G protein signaling (RGS) proteins have emerged as key regulators of signalin
158 ears ago, regulators of G protein-signaling (RGS) proteins have received considerable attention as po
159 thway-selective manner, and (3) suggest that RGS proteins help to prevent unwarranted platelet activa
162 ering promotes downregulation by placing the RGS protein in proximity to its substrate (receptor-acti
163 o downregulate signaling, loss of a specific RGS protein in sensory neurons can lead to defective res
166 ese findings establish an essential role for RGS proteins in B cell chemoattractant signaling and for
174 ss reports on the regulation and function of RGS proteins in models of psychostimulant addiction.
175 evidence has revealed key roles for specific RGS proteins in multiple signaling pathways at neuronal
177 ervations (1) demonstrate an active role for RGS proteins in regulating platelet responsiveness, (2)
178 he role of regulator of G protein signaling (RGS) proteins in the modulation of these pathways in hum
186 or screening for modulators of the G protein-RGS protein interaction by assaying the amount of produc
190 identified that the binding site for R7BP in RGS proteins is formed by pairing of the DEP (Disheveled
192 , the first biochemical function ascribed to RGS proteins, is sufficient to explain the activation ki
195 After injury, the complex gradually releases RGS proteins, limiting platelet activation and providing
197 ent evidence has raised the possibility that RGS proteins may interact directly with G-protein-couple
200 on that Galpha(i) subunits remain GTP bound, RGS proteins modulate chemoattractant receptor signaling
201 ummarize findings on the mechanisms by which RGS proteins modulate functional responses to opioids in
204 In the striatum, members of the R7 family of RGS proteins modulate signaling via D2 dopamine and mu-o
205 ation has emerged on the mechanisms by which RGS proteins modulate the efficacy of opioid analgesics
208 r findings reveal that a sizable fraction of RGS protein mutations leads to a loss of function throug
212 truncated regulator of G protein signaling (RGS) protein or a Gbetagamma-sequestering domain to a se
213 t for the adaptive coevolution of the Galpha:RGS protein pair based on single amino acid substitution
218 al mushrooms show LSEs of Galphas but not of RGS proteins pointing to the probable differentiation of
222 20-residue RGS homology domain or "RGS box." RGS proteins regulate signaling via G protein-coupled re
226 in vitro, but the physiological function of RGS proteins remains poorly defined in part because of f
230 neficial effects of serotonin, inhibition of RGS proteins represents a therapeutic approach for the t
234 highlight the current knowledge of specific RGS proteins (RGS2, RGS4, RGS7, RGS9-2, and RGS14) that
239 R7 family regulators of G protein signaling (RGS) proteins (RGS6, RGS7, RGS9, and RGS11) instead of G
240 ntains two Regulator of G-protein Signaling (RGS) proteins RGS7 and RGS11 that directly act on Go and
242 ruits the regulators of G-protein signaling (RGS) proteins, RGS7 and RGS11, to the dendritic tips of
243 conditions two equally abundant striatal R7 RGS proteins, RGS9-2 and RGS7, are unequally coupled to
244 ence that regulators of G-protein signaling (RGS) proteins serve this role in platelets, using mice w
250 the yeast regulator of G protein signaling (RGS) protein Sst2 and demonstrate that the DEP domains i
252 of the R7 regulator of G-protein signaling (RGS) protein subfamily are versatile regulators of G-pro
255 RK2 and p63RhoGEF respond similarly to these RGS proteins supports the hypothesis that GRK2 is a bona
256 NRB bind all members of the R4 subfamily of RGS proteins tested (RGS1, RGS2, RGS4, RGS16) and GAIP.
257 , a palmitoylated allosteric modulator of R7 RGS proteins that accelerate deactivation of Gi/o class
259 understanding of the molecular diversity of RGS proteins that control MOR signaling, their circuit s
260 GS7 and RGS9-2 belong to the R7 subfamily of RGS proteins that form macromolecular complexes with R7-
261 as well as regulator of G protein signaling (RGS) proteins that contain a Ggamma-like subdomain.
262 ded by the regulator of G protein signaling (RGS) proteins that deactivate G protein alpha subunits (
263 rolled by regulators of G protein signaling (RGS) proteins that shape the duration and extent of the
266 EP domain in mediating the interaction of an RGS protein to the C-terminal tail of a GPCR, thus placi
267 yses and homology modeling of the Galpha and RGS proteins to address their expansion and its potentia
268 ing that RGS2 arose from the R4-subfamily of RGS proteins to have specialized activity as a potent an
270 ings point to a critical role for endogenous RGS proteins to suppress the antidepressant-like effects
271 s to evaluate the contribution of endogenous RGS proteins to the antinociceptive effects of morphine
273 ns, and palmitoylation of R7BP can target R7 RGS proteins to the plasma membrane in cultured cells.
275 ain GTP bound, and the loss of an individual RGS protein typically enhances chemokine receptor signal
276 n of gene transcription, can be regulated by RGS proteins via both allosteric and GAP mechanisms.
278 ion-based adaptive coevolution of the Galpha:RGS proteins was proposed to enable the loss of RGS in m
281 These regulators of G-protein signaling (RGS) proteins were viewed by many as nodes downstream of
283 (GAPs), both phospholipase C (PLC)-betas and RGS proteins, when assayed in solution under single turn
285 ) is a member of a family of proteins called RGS proteins, which function as GTPase-activating protei
286 ve NFR1 receptors phosphorylate and activate RGS proteins, which help maintain the Galpha proteins in
287 ns and the regulator of G-protein signaling (RGS) proteins, which accelerate the inherent GTPase acti
288 ) bound by regulator of G-protein signaling (RGS) proteins, which function as GTPase-activating prote
290 ped by the regulator of G protein signaling (RGS) proteins, which promote G protein deactivation.
291 Rgs6(-/-) mice is attributable to another R7 RGS protein whose influence on M2R-IKACh signaling is ma
293 The soybean genome encodes two chimeric RGS proteins with an N-terminal seven transmembrane doma
295 g 9-1 (RGS9-1) and RGS9-2 are highly related RGS proteins with distinctive C termini arising from alt
297 se findings argue that the association of R7 RGS proteins with the membrane environment provides a ma
298 mplexes of regulator of G-protein signaling (RGS) proteins with G-protein beta5 (Gbeta5) subunits are
299 regulation, and functional role of canonical RGS proteins, with a special focus on the healthy heart
300 At neuronal synapses, GPCRs, G proteins, and RGS proteins work in coordination to regulate key aspect